AAC
Showing 1 - 25 of 531
Intellectual Disability, Speech and Language Disorder Trial in Portland (Early Augmentative and Alternative Communication (AAC)
Recruiting
- Intellectual Disability
- Speech and Language Disorder
- Early Augmentative and Alternative Communication (AAC) Intervention
-
Portland, OregonOregon Health and Science University
Feb 22, 2023
Community-dwelling Older Adults Trial in Singapore (SinDance)
Recruiting
- Community-dwelling Older Adults
- SinDance
-
Singapore, Singapore
- +2 more
May 31, 2023
Communication Disabilities Trial in Messina (AAC + Eye Tracking, AAC)
Recruiting
- Communication Disabilities
- AAC + Eye Tracking
- AAC
-
Messina, ItalyIRCCS Neurolesi Bonino Pulejo
Mar 30, 2023
Communication Disorders Trial in Natick, Lincoln (Experimental AAC, Generic AAC)
Completed
- Communication Disorders
- Experimental AAC
- Generic AAC
-
Natick, Massachusetts
- +1 more
Feb 2, 2022
Real World Testing of a Brain-Computer Interface
Recruiting
- Amyotrophic Lateral Sclerosis
- +4 more
- Speech generating device (SGD) evaluation including BCI access
- Training and treatment
-
Carnegie, Pennsylvania
- +1 more
Oct 6, 2022
Adult Solid Tumor Trial in Spain, United States (SQZ-AAC-HPV, Ipilimumab, Nivolumab)
Recruiting
- Adult Solid Tumor
- SQZ-AAC-HPV
- +2 more
-
Duarte, California
- +5 more
Aug 12, 2022
Literacy Trial in State College (ALL Phonics Instruction, ALL Sight Word Instruction)
Enrolling by invitation
- Literacy
- ALL Phonics Instruction
- ALL Sight Word Instruction
-
State College, PennsylvaniaThe Pennsylvania State University
Oct 26, 2022
Anxiety, Depression Trial in Tulsa (Behavioral Activation, Exposure-based therapy, Supportive therapy)
Recruiting
- Anxiety
- Depression
- Behavioral Activation
- +2 more
-
Tulsa, OklahomaLaureate Institute for Brain Research
Oct 18, 2021
Tobacco Use Cessation, Cardiovascular Diseases, Tobacco Use Trial in Minneapolis, Rochester (Longitudinal Proactive Outreach
Not yet recruiting
- Tobacco Use Cessation
- +4 more
- Longitudinal Proactive Outreach (LPO).
- Ask-Advice-Connect (AAC)
-
Minneapolis, Minnesota
- +2 more
Jan 2, 2023
Down Syndrome, Speech and Language Disorder, Speech Disorders in Children Trial in Orlando, Albuquerque (AAC Generative Language
Recruiting
- Down Syndrome
- +4 more
- AAC Generative Language Intervention
- Standard of Care / Business as Usual
-
Orlando, Florida
- +1 more
May 13, 2021
Down Syndrome, Augmentative and Alternative Communication Trial in University Park (AAC Technology - Standard of Care, AAC
Recruiting
- Down Syndrome
- Augmentative and Alternative Communication
- AAC Technology - Standard of Care
- AAC Technology - non-optimal integrated arrangement
-
University Park, Pennsylvania11 Ford Building
Mar 10, 2021
Smoking, Tobacco Dependence Trial (Teachable Moment Communication Process, AAC)
Completed
- Smoking
- Tobacco Dependence
- Teachable Moment Communication Process
- AAC
- (no location specified)
Jul 26, 2021
Learning Disabilities, Cerebral Palsy, Down Syndrome Trial in Rawalpindi (Rhymes, Individual Items in Rhymes, Objects)
Completed
- Learning Disabilities
- +2 more
- Rhymes
- +2 more
-
Rawalpindi, Punjab, PakistanRiphah Child Development Centre & Step to Learn School
Mar 30, 2021
Hepatic Encephalopathy, Liver Cirrhosis, Sleep Disturbance Trial in Copenhagen (Amino Acid Challenge (AAC))
Completed
- Hepatic Encephalopathy
- +2 more
- Amino Acid Challenge (AAC)
-
Copenhagen, DenmarkDepartment of gastroenterology and hepatology, Rigshospitalet
Mar 14, 2021
Diabetic Nephropathy Trial in Worldwide (Nidufexor, Placebo, Standard of Care (SoC))
Type 2 Diabetes, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- Obesity
- Tirzepatide
- Placebo
-
Caba, Buenos Aires, Argentina
- +48 more
Sep 8, 2023
Allergic Conjunctivitis Trial in Caba (Bepotastine Besilate 1.5% PF, Olopatadine Hydrochloride 0.2% BAK)
Recruiting
- Allergic Conjunctivitis
- Bepotastine Besilate 1.5% PF
- Olopatadine Hydrochloride 0.2% BAK
-
Caba, Argentina
- +3 more
Mar 29, 2021
Obese Patients With Non-alcoholic Steatohepatitis (NASH) Trial in Worldwide (LIK066, Placebo)
Completed
- Obese Patients With Non-alcoholic Steatohepatitis (NASH)
- LIK066
- Placebo
-
Baton Rouge, Louisiana
- +14 more
Oct 7, 2021
Intellectual Disabilities Trial in Halden, Borre (Reading intervention)
Recruiting
- Intellectual Disabilities
- Reading intervention
-
Halden, BRA Veien, Norway
- +1 more
Jan 23, 2023
ADjuvant chemotherAPy After Curative Intent resecTion of
Recruiting
- Ampullary Adenocarcinoma
-
Brescia, BS, ItalyFondazione Poliambulanza
Oct 3, 2023
Neurocognitive Disorders, Alzheimer, Caregiver Trial in Birmingham, Miami (CareHeroes)
Not yet recruiting
- Neurocognitive Disorders
- +2 more
- CareHeroes
-
Birmingham, Alabama
- +1 more
Oct 5, 2022
Rehabilitation of Speech and Language Disorders, Speech Disorders, Speech, Alaryngeal Trial in Natick (MyoVoice, Electrolarynx)
Recruiting
- Rehabilitation of Speech and Language Disorders
- +5 more
- MyoVoice
- Electrolarynx
-
Natick, MassachusettsAltec Inc.
Mar 18, 2022
Type 1 Diabetes Trial in Argentina, China, Mexico (LY900014, Insulin Lispro, Insulin Glargine)
Completed
- Type 1 Diabetes Mellitus
- LY900014
- +3 more
-
Caba, Buenos Aires, Argentina
- +29 more
Feb 18, 2022
Cancer, Tobacco Dependence, Tobacco Use Cessation Trial in San Francisco (behavioral, other, procedure)
Not yet recruiting
- Cancer
- +2 more
- CareConnect
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 13, 2023
Post-stroke Aphasia, Aphasia Trial in Cincinnati (AAC for Language Recovery (AAC-LaRc))
Unknown status
- Post-stroke Aphasia
- Aphasia
- AAC for Language Recovery (AAC-LaRc)
-
Cincinnati, OhioUniversity of Cincinnati
Sep 4, 2019